Funding for growth Amprion has recently secured significant funding, including a $6 million Series B financing round and a $15 million investment from Formation Venture Engineering. This influx of capital will support business expansion, potentially creating opportunities for partnership development and increased market reach.

Partnership potential Amprion is actively partnering with pharmaceutical companies to develop therapies for neurodegenerative disorders like Parkinson's disease. These collaborations present sales opportunities for offering diagnostic solutions, biomarker testing, and research tools to support drug development efforts of these partners.

Innovative product launches With the recent launch of SAAmplify Biomarker Tests and a new line of cerebrospinal fluid biomarker panels, Amprion is continuously innovating and introducing cutting-edge diagnostic tools to the market. Sales professionals can leverage these unique products to offer advanced solutions to healthcare institutions and research organizations.

Research grant utilization Amprion's receipt of a $100,000 research grant indicates a commitment to advancing scientific research in the field of neurodegenerative disorders. Sales teams can explore collaboration opportunities with Amprion based on the shared goal of driving research forward, potentially leading to sales of equipment, consumables, or services.

Expansion plans in motion CEO Russell Lebovitz's announcement of hiring 15 more employees and expanding sales operations across the US signals growth and increased market presence for Amprion. Business development professionals can explore collaboration and distribution agreements to support Amprion's expansion plans and tap into emerging sales opportunities.